ARCHIVES

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

This article is from The Cancer Letter archive.

Vol. 36 No. 04 | February 5, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

Report On Carcinogenesis Testing, Evaluation Submitted to NTP; Calls For Continued Research

September 7, 1984

ACCP and ASCO Publish Joint Guideline Following Review of Evidence on Low-Dose CT

May 25, 2012

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

Surgeon General Issues Call To Reduce Skin Cancer Rates

August 1, 2014

DCT Programs Status Reported to Board

July 5, 1985